John J Turchi

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

NAR cancer

Molecular cancer research : MCR

Cellular and molecular life sciences : CMLS

ChemMedChem

This page only lists publications with an associated author ORCID identifier.

Publications

Pamela L Mendoza-Munoz, Navnath S Gavande, Pamela S VanderVere-Carozza, Katherine S Pawelczak, Joseph R Dynlacht, Joy E Garrett, John J Turchi
Ku-DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks. NAR cancer 5 (1) (2023)
Pamela L Mendoza-Munoz, Navnath S Gavande, Pamela S VanderVere-Carozza, Katherine S Pawelczak, Joseph R Dynlacht, Joy E Garrett, John J Turchi
Ku-DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks. NAR cancer 5 (1) (2023)
Joshua R Heyza, Elmira Ekinci, Jacob Lindquist, Wen Lei, Christopher Yunker, Vilvanathan Vinothkumar, Rachelle Rowbotham, Lisa Polin, Natalie G Snider, Eric Van Buren, Donovan Watza, Jessica B Back, Wei Chen, Hirva Mamdani, Ann G Schwartz, John J Turchi, Gerold Bepler, Steve M Patrick
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe. NAR cancer 5 (1) (2023)
Diana Ainembabazi, Youwei Zhang, John J Turchi
The mechanistic role of cardiac glycosides in DNA damage response and repair signaling. Cellular and molecular life sciences : CMLS 80 (9) (2023)
Joshua R Heyza, Elmira Ekinci, Jacob Lindquist, Wen Lei, Christopher Yunker, Vilvanathan Vinothkumar, Rachelle Rowbotham, Lisa Polin, Natalie G Snider, Eric Van Buren, Donovan Watza, Jessica B Back, Wei Chen, Hirva Mamdani, Ann G Schwartz, John J Turchi, Gerold Bepler, Steve M Patrick
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe. NAR cancer 5 (1) (2023)
Joshua R Heyza, Elmira Ekinci, Jacob Lindquist, Wen Lei, Christopher Yunker, Vilvanathan Vinothkumar, Rachelle Rowbotham, Lisa Polin, Natalie G Snider, Eric Van Buren, Donovan Watza, Jessica B Back, Wei Chen, Hirva Mamdani, Ann G Schwartz, John J Turchi, Gerold Bepler, Steve M Patrick
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe. NAR cancer 5 (1) (2023)
Diana Ainembabazi, Xinran Geng, Navnath S Gavande, John J Turchi, Youwei Zhang
Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage Response. ChemMedChem 17 (21) (2022)
Shruthi Sriramkumar, Timothy D Matthews, Ahmed H Ghobashi, Samuel A Miller, Pamela S VanderVere-Carozza, Katherine S Pawelczak, Kenneth P Nephew, John J Turchi, Heather M O'Hagan
Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer. Molecular cancer research : MCR 18 (11) (2020)
Navnath S Gavande, Pamela VanderVere-Carozza, Akaash K Mishra, Tyler L Vernon, Katherine S Pawelczak, John J Turchi
Design and Structure-Guided Development of Novel Inhibitors of the Xeroderma Pigmentosum Group A (XPA) Protein-DNA Interaction. Journal of medicinal chemistry 60 (19) (2017)

John J Turchi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

John J Turchi